An assessment of the psychosocial needs of Huntington's disease families
β Scribed by Gregory J. Meissen; Eugene Maguin; Ann Woodruff
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 548 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0090-4392
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract With prospects improving for experimental therapeutics aimed at postponing the onset of illness in preclinical carriers of the Huntington's disease (HD) gene, we assessed agreement among experienced clinicians with respect to the motor manifestations of HD, a relevant outcome measure fo
## Abstract We performed a 6βmonth openβlabel trial to evaluate the tolerability and efficacy of coenzyme Q10 (CoQ) in 10 patients with Huntington's disease (HD), Subjects were evaluated at baseline, 3 months, and 6 months using the HD Rating Scale (HDRS), the HD Functional Capacity Scale (HDFCS),
Clinical rating, caudate atrophy, disturbed movement performance, neuropsychological testing, and age-related genetic disease load (CAG index) are tools that reflect impairment after onset of Huntington's disease (HD). Objectives were to compare scored HD symptoms, results of neuropsychological test
Assessment programs recently designed to follow-up patients with Huntington's disease (HD) in therapeutic trials have not included electrophysiological testing in the list of mandatory examinations. This omission is likely due to the current lack of data establishing a clear correlation between the